特发性肺纤维化（IPF）作为一种罕见且预后较差的间质性肺疾病，其治疗需求长期未被满足。目前中国已上市的吡非尼酮和尼达尼布虽可延缓轻中度 ...

The drug is designed to treat idiopathic pulmonary fibrosis (IPF) by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular ...

The CDC put together an analysis of what's called Idiopathic Pulmonary Fibrosis (IPF). It's a lung condition that comes from scarring and declining lung function. Researchers found from 2020 to ...